Novo CEO pressed by Senate to chop costs of weight problems, diabetic issues medications CEO Lars Fruergaard Jørgensen told lawmakers the organization would consider new talks with insurers in regards to the record charges of Wegovy and copyright if they pledge to help keep the medicines on their own formularies. https://johnathanulcsj.bloggip.com/30707284/healthcare-news-things-to-know-before-you-buy